To investigate the clinical effect of combination therapy with high-frequency oscillation ventilation ( HFOV ) , pulmonary surfactant ( PS ) and inhaled nitric oxide ( iNO ) in the treatment of neonatal hypoxemic respiratory failure ( HRF ) .